CARLSBAD, Calif., — Life Technologies Corporation (NASDAQ: LIFE) today announced results for its first quarter ended March 31, 2013. Revenue for the first quarter was $963 million, an increase of 2.5 percent over the $939 million reported for the first quarter of 2012. Excluding the impact of currency, revenue growth for the quarter was 4.4 […]

Franklin Lakes, NJ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.0 billion for the second fiscal quarter ended March 31, 2013, representing an increase of 3.7 percent from the prioryear period, or 4.1 percent on a foreign currency-neutral basis. “We continued to deliver […]

HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that it continues to believe that the best path to maximizing value for its shareholders is to spin-off Harvard Apparatus Regenerative Technology, Inc., or HART, its […]

LEXINGTON, Mass – RainDance Technologies, Inc., the Digital Biology™ Company, today announced the closing of a $20 million Series E financing round. The company also announced that Myriad Genetics, Inc. (Nasdaq: MYGN) has joined as a new strategic equity investor. The two companies recently announced a multi-year commercial supply agreement whereby Myriad has adopted RainDance’s […]

Qlucore, a world leader in the development of bioinformatics software, today announces it will develop an enhanced NGS-enabled release of Qlucore Omics Explorer. A recent grant awarded by VINNOVA, the Swedish Governmental Agency for Innovation Systems, now makes it possible for Qlucore to implement its NGS solution. Genome research has advanced significantly in recent years, […]

HIGHLIGHTS: Q1 2013 Results (all percentages are to comparable periods in 2012) Q1 2013 reported sales increased 2% to $675 million, a new quarterly high. Organic sales growth was 1% in the quarter. Organic sales growth by business unit was (1%) for Research, 3% for Applied and 3% for SAFC Commercial. Acquisitions completed in 2012 […]

CAMBRIDGE, Mass. and SANTA CLARA, Calif. — Gen9, Inc., a pioneer in the development of scalable technologies for synthesizing genes, and Agilent Technologies (NYSE: A) today announced the closing of a $21 million strategic investment from Agilent in Gen9. Gen9 will use these funds to further invest in product development and to expand the commercial […]

WALTHAM, Mass.– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2013. First Quarter 2013 Highlights Adjusted earnings per share (EPS) grew 17% to a record $1.37 Revenue increased 4% to a first quarter record of $3.19 billion Adjusted operating […]